Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Comparison of Outcomes in Chronic Lymphocytic Leukemia (CLL) with the Addition of Rituximab to Initial Treatment: A Comparative Effectiveness Analysis in the Province of British Columbia (BC), Canada

Lauren J. Lee, MD, Alina S. Gerrie, MD FRCPC, Helene Bruyere, MD FCCMG, Tanya L. Gillan, PhD FCCMG, Stephen J.T. Huang, BMLSc, Cynthia L. Toze, MD FRCPC, Khaled M. Ramadan, MBBCh, MRCPI, FRCPath, FRCP, FRCPC

Blood (2014) 124 (21): 3344.

https://doi.org/10.1182/blood.V124.21.3344.3344

Published: 2014

Journal Articles

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Sebastian J. Swic, Alexander G. T. MacPhail, Chinmay B. Dalal, MD, Steven J.T. Huang, BMLSc, Alina S. Gerrie, MD FRCPC, Thomas J. Nevill, MD, Heather J. Sutherland, MD PhD FRCPC, Raewyn Broady, MBChB, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Kevin Song, MD, Yasser R Abou Mourad, MD FRCPC, Donna E. Hogge, MD PhD FRCPC, Maryse M. Power, MD MRCPI, FRCPath, Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Donna L. Forrest, MD, Sean S Young, PhD DABMG, FACMG, FCCMG, Tanya L. Gillan, PhD FCCMG, Cynthia L. Toze, MD FRCPC

Blood (2014) 124 (21): 2549.

https://doi.org/10.1182/blood.V124.21.2549.2549

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Failing Treatment with Tyrosine Kinase Inhibitors

Anish Nair, MD, Michael J Barnett, BM, Donna E. Hogge, MD PhD, Kevin Song, MD, Cynthia L. Toze, MD FRCPC, Stephen H. Nantel, MD FRCPC, Maryse M Power, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Raewyn Broady, MBChB, FRACP, Heather J. Sutherland, MD PhD FRCPC, Thomas J. Nevill, MD FRCPC, Yasser R Abou Mourad, MD FRCPC, Alina S. Gerrie, MD FRCPC, Donna L. Forrest, MD

Blood (2014) 124 (21): 1250.

https://doi.org/10.1182/blood.V124.21.1250.1250

Published: 2014

Journal Articles

Effect of Physical Activity (PA) Interventions On Health-Related Quality of Life (HRQoL) Post Hematopoietic Stem Cell Transplantation (HSCT): A Systematic Review and Meta-Analysis

Alina S. Gerrie, MD, FRCPC, MPH, Siobhan White, PhD, MPH, Katherine L. Harvey, MD, MPH, Ritu Gill, MD, MPH, Cynthia L. Toze, MD, FRCP(C)

Blood (2012) 120 (21): 1968.

https://doi.org/10.1182/blood.V120.21.1968.1968

Published: 2012

Journal Articles

Clonal Evolution Predicts Poor Prognosis in Chronic Lymphocytic Leukaemia and Is Possibly a Worse Prognostic Factor Than 17p Deletion: A Population Based Cohort study of FISH Testing in British Columbia, Canada

Krystal Bergin, MBBS, Alina S. Gerrie, MD, FRCPC, Steven J.T. Huang, BMLSc, Khaled M Ramadan, MBBCH, MRCPI, FRCPath, FRCP, FRCPC, Aly Karsan, MD, Monica Anne Hrynchak, MD, FRCP(C), Chinmay B. Dalal, MD, Helene Bruyere, MD, FCCMG, Adam C. Smith, PhD, FCCMG, FACMG, Cynthia L. Toze, MD, MHSc, FRCPC, Tanya L. Gillan, PhD, FCCMG

Blood (2012) 120 (21): 1401.

https://doi.org/10.1182/blood.V120.21.1401.1401

Published: 2012

Journal Articles

Comprehensive Assessment of Clinical Outcomes for CLL Patients with Trisomy 12 (+12): Results of a Population-Based Analysis of 822 CLL Patients in British Columbia (BC), Canada

Alina S. Gerrie, MD, FRCPC, MPH, Steven J.T. Huang, BMLSc, Helene Bruyere, MD, FCCMG, Chinmay B. Dalal, MD, Monica Anne Hrynchak, MD, FRCP(C), Aly Karsan, MD, Khaled M Ramadan, MBBCH, MRCPI, FRCPath, FRCP, FRCPC, Adam C. Smith, PhD, FCCMG, FACMG, Tanya L. Gillan, PhD, FCCMG, Cynthia L. Toze, MD, FRCP(C)

Blood (2012) 120 (21): 3897.

https://doi.org/10.1182/blood.V120.21.3897.3897

Published: 2012

Journal Articles

Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma

Alina S. Gerrie, MD, FRCPC, Maryse M. Power, MD, FRCPath, Kerry J. Savage, MD MSc, John D. Shepherd, MD, FRCPC, Joseph M. Connors, MD

Blood (2011) 118 (21): 2022.

https://doi.org/10.1182/blood.V118.21.2022.2022

Published: 2011

Journal Articles

Fludarabine and Rituximab (FR) Is a Safe and Effective Treatment Alternative for Relapsed or Refractory Hairy Cell Leukemia (HCL)

Alina S. Gerrie, MD, FRCPC, Leslie N. Zypchen, MD, FRCPC, Joseph M. Connors, MD

Blood (2010) 116 (21): 2454.

https://doi.org/10.1182/blood.V116.21.2454.2454

Published: 2010

Journal Articles

Impact of Immunoglobulin Heavy Chain (IGH) Translocations In Chronic Lymphocytic Leukemia (CLL): Negative Effect on Patients with Isolated Deletion 13q Abnormality

Alina S. Gerrie, MD, FRCPC, Tanya L. Gillan, PhD, FCCMG, Helene Bruyere, MD, FCCMG, Mary Joyce Chan, BMLSc, Chinmay B. Dalal, MD, Cynthia L. Toze, MD, FRCPC

Blood (2010) 116 (21): 2434.

https://doi.org/10.1182/blood.V116.21.2434.2434

Published: 2010

Journal Articles

Fludarabine (F) and Rituximab (R) (FR) as Initial Therapy for Symptomatic Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL): Population-Based Experience Matches Clinical Trials.

Alina S. Gerrie, MD, FRCPC, Cynthia L. Toze, MD, FRCP(C), Khaled M. Ramadan, MB, Charles H. Li, MD, Adrian Yee, MD, FRCPC, Joseph M. Connors, MD

Blood (2009) 114 (22): 2363.

https://doi.org/10.1182/blood.V114.22.2363.2363

Published: 2009

NARROW

Comparison of Outcomes in Chronic Lymphocytic Leukemia (CLL) with the Addition of Rituximab to Initial Treatment: A Comparative Effectiveness Analysis in the Province of British Columbia (BC), Canada

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Failing Treatment with Tyrosine Kinase Inhibitors

Effect of Physical Activity (PA) Interventions On Health-Related Quality of Life (HRQoL) Post Hematopoietic Stem Cell Transplantation (HSCT): A Systematic Review and Meta-Analysis

Clonal Evolution Predicts Poor Prognosis in Chronic Lymphocytic Leukaemia and Is Possibly a Worse Prognostic Factor Than 17p Deletion: A Population Based Cohort study of FISH Testing in British Columbia, Canada

Comprehensive Assessment of Clinical Outcomes for CLL Patients with Trisomy 12 (+12): Results of a Population-Based Analysis of 822 CLL Patients in British Columbia (BC), Canada

Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma

Fludarabine and Rituximab (FR) Is a Safe and Effective Treatment Alternative for Relapsed or Refractory Hairy Cell Leukemia (HCL)

Impact of Immunoglobulin Heavy Chain (IGH) Translocations In Chronic Lymphocytic Leukemia (CLL): Negative Effect on Patients with Isolated Deletion 13q Abnormality

Fludarabine (F) and Rituximab (R) (FR) as Initial Therapy for Symptomatic Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL): Population-Based Experience Matches Clinical Trials.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only